Browse All

Current Filters

CLEAR FILTER x

TITLE

Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer cells (NK) and natural killer-T cells (NKT) in neuromyelitis optica spectrum disorder.

Author:Nishiyama, Shuhei   Wright, Amy   Lotan, Itay   Paul, Friedemann   Levy, Michael   

Session Name:S50: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:S50.003  

Author Institution:Massachusetts General Hospital/Harvard Medical School, Boston, MA  Massachusetts General Hospital, Charlestown, MA  Charite Universitatsmedizin in Berlin, Berlin, Germany  

Extracellular RNA splice events in cerebrospinal fluid as candidate biomarkers of myotonic dystrophy type 1

Author:Kumari, Preeti   Hu, Ningyan   Sizemore, Alex   Sullivan, Lauren   Mckee, Brigham   Conquest, Parker   Wheeler, Thurman   

Session Name:N4: Neuroscience in the Clinic: Bridging Genetics to the Clinic in Neuromuscular Disease  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:N4.004  

Author Institution:Massachusetts General Hospital, Charlestown, MA  

Multiple Sclerosis Research Across the African Continent: A Systematic Review

Author:Hwang, Soonmyung   George, Ilena   Garcia-Dominguez, Maria A.   Salasky, Vanessa   Vishnevetsky, Anastasia   Miskin, Dhanashri   Tran, Andy   Chiluba, Brian   Saylor, Deanna   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.002  

Author Institution:Icahn School of Medicine at Mount Sinai , New York, NY  Massachusetts General Hospital, Charlestown, MA  Johns Hopkins Bloomberg School of Public Health, Baltimore, MD  University of Maryland, Baltimore, MD  Massachusetts General Hospital, Brigham, Harvard, Winchester, MA  Thomas Jefferson University, Philadelphia, PA  University of Iowa Carver College of Medicine, Lincolnwood, IL  University of Zambia, Lusaka, Zambia  Johns Hopkins Hospital, Baltimore, MD  

Towards a Trauma Subtype of Functional Neurological Disorder: Impact on Symptom Severity and Physical Health

Author:Perez, David   Guthrie, Andrew J.   Paredes-Echeverri, Sara   

Session Name:P5: Behavioral and Cognitive Neurology in Clinical Practice  

Topic:Behavioral and Cognitive Neurology  

Program Number:P5.007  

Author Institution:Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital, Charlestown, MA  

Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations

Author:Berry, James   Maragakis, Nicholas   Paganoni, Sabrina   Quintana, Melanie   Macklin, Eric   Saville, Benjamin   Andrews, Jinsy   Shefner, Jeremy   Detry, Michelle   Menon, Parvathi   Huynh, William   Mahoney, Colin   Stommel, Elijah   Hall, Meghan   Connolly, Mariah   Kittle, Gale   Chase, Marianne   Sherman, Alexander   Yu, Hong   Pothier, Lindsay   Drake, Kristin   Chibnik, Lori   Bind, Marie-Abele   Vestrucci, Matteo   Glanzman, Robert   Hotchkin, Michael   Vucic, Steve   Kiernan, Matthew   Cudkowicz, Merit   Study Group, HEALEY ALS Platform Trial   Investigators, RESCUE-ALS   

Session Name:P8: Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P8.004  

Author Institution:Massachusetts General Hospital, Boston, MA  Johns Hopkins University School of Medicine, Baltimore, MD  Berry Consultants, San Francisco, CA  MGH Biostatistics Center, Boston, MA  Columbia University Medical Center, New York, NY  Barrow Neurological Institute, Phoenix, AZ  Westmead Public Hospital, Sydney, Australia  Prince of Wales Hospital, Randwick, Australia  University of Sydney, Sydney, Australia  Dartmouth-Hitchock Med Ctr/Dept of Neuro, Lebanon, NH  Massachusetts General Hospital, Charlestown, MA  Clene Nanomedicine Inc, Holladay, UT  Clene Nanomedicine, Inc., Salt Lake City, UT  Brain and Mind Centre, Sydney, Australia  HEALEY ALS Platform Trial, Boston, MA  RESCUE-ALS Trial, Sydney, Australia